Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion type Assertion NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_head.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion evidence source_evidence_literature NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion SIO_000772 19883730 NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion wasDerivedFrom befree-20140225 NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.
- NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_assertion wasGeneratedBy ECO_0000203 NP678626.RAfqntwD2LfSj-4Y3VOBRKOqLW9qmeAdOJl0JLHL_mKVI130_provenance.